Radiopharm Theranostics Limited (RADX)

Profile

Full Name

Radiopharm Theranostics Limited

Ticker

NASDAQ: RADX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Australia

IPO

December 5, 2024

Indexes

Not included

Website

https://www.radiopharmtheranostics.com

Employees

-

Key Details

Price

$14.12(231.46%)

Market Cap

$109.85M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$2.35M(1099.95% YoY)

Annual EPS

-$3.43(85.95% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.12
    RADX price is $14.12

    30-Day Relative Volume

    1102.73
    RADX 30-day relative volume is 1102.73

    Price Performance

    Price 1-Day Change

    +231.46%
    RADX price is up +231.46% today

    Price YTD Change

    +214.48%
    RADX price is up +214.48% since January 1st

    Price 1-Year Change

    +150.8%
    RADX price is up +150.8% year-on-year

    Price 3-Year Change

    -
    RADX price 3-year change is unknown

    Price Range

    Price All-Time High

    $50.82
    RADX price is currently -72.22% below its historical high of $50.82

    Price 3-Year Low

    $3.50
    RADX price is currently +303.89% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $109.85M
    RADX market cap is $109.85 million

    Market Cap 3-Year Change

    -
    RADX market cap 3-year change is unknown

    Market Cap All-Time High

    $136.90M
    RADX market cap is currently -19.76% below its historical high of $136.90 million

    Market Cap Sector Percentile

    42%
    RADX market cap is higher than 42% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +7.41%
    RADX shares outstanding is up +7.41% year-on-year

    Shares Outstanding 3-Year Change

    +570.97%
    RADX shares outstanding is up +570.97% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.33
    RADX beta is 0.33

    200-day SMA

    $5.09
    RADX price is currently +177.66% above its 200-day simple moving average

    50-day SMA

    $5.29
    RADX price is currently +167.02% above its 50-day simple moving average

    14-Day RSI

    40.32
    RADX 14-day relative strength index is 40.32

    Volume

    1102.73
    RADX 30-day relative volume is 1102.73

    ATR

    $0.45
    RADX average true range is $0.45

    10-day Historical Volatility

    77.20%
    RADX 10-day historical volatility is 77.20%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.35M
    RADX annual revenue is $2.35 million

    Revenue Analysts Estimate

    $395.50K
    RADX annual revenue is currently +494.97% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +1099.95%
    RADX annual revenue is up +1099.95% year-on-year

    Revenue Sector Percentile

    39.53%
    RADX annual revenue is higher than 39.53% of companies in Healthcare sector

    EPS

    EPS

    -$3.43
    RADX annual earnings per share is -$3.43

    EPS Analysts Estimate

    -$3.29
    RADX annual earnings per share is currently -4.33% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +85.95%
    RADX annual earnings per share is up +85.95% year-on-year

    EPS Sector Percentile

    27.9%
    RADX annual earnings per share is higher than 27.9% of companies in Healthcare sector

    Profit

    Gross Profit

    -$1.66M
    RADX annual gross profit is -$1.66 million

    Gross Margin

    -70.36%
    RADX annual gross profit margin is -70.36%

    Operating Profit

    -$28.50M
    RADX annual operating income is -$28.50 million

    Operating Margin

    -1211.24%
    RADX annual operating profit margin is -1211.24%

    Net Income

    -$24.83M
    RADX annual net profit is -$24.83 million

    Net Margin

    -1055.28%
    RADX annual net profit margin is -1055.28%

    Expenses

    Total Expenses

    $27.18M
    RADX annual total expenses is $27.18 million

    Operating Expenses

    $26.85M
    RADX annual total operating expenses is $26.85 million

    Cost Of Goods Sold

    $4.01M
    RADX annual cost of goods sold is $4.01 million

    Selling, General & Administrative Expenses

    $0.00
    RADX annual SG&A is $0.00

    Depreciation & Amortization

    $1.68M
    RADX annual D&A is $1.68 million

    Interest Expense

    $0.00
    RADX annual interest expense is $0.00

    Income Tax

    $66.90K
    RADX annual income tax is $66.90 thousand

    EBIT & EBITDA

    EBIT

    -$28.50M
    RADX annual earnings before interest & taxes is -$28.50 million

    EBITDA

    -$26.82M
    RADX annual EBITDA is -$26.82 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $56.68M
    RADX annual total assets is $56.68 million

    Non Current Assets

    $30.56M
    RADX annual long term assets is $30.56 million

    Current Assets

    $26.12M
    RADX annual total current assets is $26.12 million

    Cash and Cash Equivalents

    $19.08M
    RADX annual cash & cash equivalents is $19.08 million

    Accounts Receivable

    $6.82M
    RADX annual accounts receivable is $6.82 million

    Inventory

    $0.00
    RADX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $28.58M
    RADX annual total liabilities is $28.58 million

    Long Term Liabilities

    $18.79M
    RADX annual total long term liabilities is $18.79 million

    Current Liabilities

    $9.79M
    RADX annual current liabilities is $9.79 million

    Accounts Payable

    $4.16M
    RADX annual accounts payable is $4.16 million

    Debt

    Total Debt

    $0.00
    RADX annual total debt is $0.00

    Total Debt 1-Year Change

    0%
    RADX annual total debt has remained unchanged year-on-year

    Long Term Debt

    $0.00
    RADX annual long term debt is $0.00

    Short Term Debt

    $0.00
    RADX annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $29.35M
    RADX annual stockholders equity is $29.35 million

    Book Value

    $29.35M
    RADX annual book value is $29.35 million

    Retained Earnings

    -$95.51M
    RADX annual retained earnings is -$95.51 million

    Working Capital

    $16.33M
    RADX annual working capital is $16.33 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$23.73M
    RADX annual cash from operations is -$23.73 million

    Cash From Operations 1-Year Change

    -57.63%
    RADX annual cash from operations is down -57.63% year-on-year

    Cash From Investing

    $1.15M
    RADX annual cash from investing is $1.15 million

    Cash From Investing 1-Year Change

    +100%
    RADX annual cash from investing is up +100% year-on-year

    Cash From Financing

    $29.42M
    RADX annual cash from financing is $29.42 million

    Cash From Financing 1-Year Change

    +50.29%
    RADX annual cash from financing is up +50.29% year-on-year

    CAPEX

    CAPEX

    $794.60K
    RADX annual capital expenditures is $794.60 thousand

    CAPEX 1-Year Change

    +100%
    RADX annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$24.53M
    RADX annual free cash flow is -$24.53 million

    Free Cash Flow 1-Year Change

    -62.91%
    RADX annual free cash flow is down -62.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -70.36%
    RADX annual gross profit margin is -70.36%

    Operating Margin

    -1211.24%
    RADX annual operating profit margin is -1211.24%

    Net Margin

    -1055.28%
    RADX annual net profit margin is -1055.28%

    ROA & ROE

    ROA

    -47.40%
    RADX annual return on assets is -47.40%

    ROE

    -107.12%
    RADX annual return on equity is -107.12%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    RADX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    RADX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    3.32
    RADX price to book ratio is 3.32

    PB Ratio Sector Percentile

    64.08%
    RADX price to book ratio is higher than 64.08% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    RADX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    RADX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $87.19M
    RADX enterprise value is $87.19 million

    Enterprise Value Sector Percentile

    42.23%
    RADX enterprise value is higher than 42.23% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    RADX EV/EBITDA value is unknown

    EV/EBITDA Sector Percentile

    -
    RADX EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.67
    RADX annual current ratio is 2.67

    Quick Ratio

    2.67
    RADX annual quick ratio is 2.67

    Leverage

    Debt To Equity

    0.00
    RADX annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    RADX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    RADX piotroski f-score value is unknown

    Altman Z-Score

    -1.33
    RADX altman z-score is -1.33

    Analyst ratings

    Recent major analysts updates

    Nov 26, 25 B. Riley Securities
    Buy
    Jul 21, 25 Brookline Capital
    Buy
    May 1, 25 Maxim Group
    Buy
    Mar 12, 25 B. Riley Securities
    Buy

    Institutional Ownership

    Screeners with RADX included

    Growing Shares Outstanding
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    Stocks with low beta
    • What is the ticker symbol for Radiopharm Theranostics Limited?
    • Does Radiopharm Theranostics Limited pay dividends?
    • What sector is Radiopharm Theranostics Limited in?
    • What industry is Radiopharm Theranostics Limited in?
    • What country is Radiopharm Theranostics Limited based in?
    • When did Radiopharm Theranostics Limited go public?
    • Is Radiopharm Theranostics Limited in the S&P 500?
    • Is Radiopharm Theranostics Limited in the NASDAQ 100?
    • Is Radiopharm Theranostics Limited in the Dow Jones?
    • When was Radiopharm Theranostics Limited's last earnings report?
    • When does Radiopharm Theranostics Limited report earnings?

    What is the ticker symbol for Radiopharm Theranostics Limited?

    The ticker symbol for Radiopharm Theranostics Limited is NASDAQ:RADX

    Does Radiopharm Theranostics Limited pay dividends?

    No, Radiopharm Theranostics Limited does not pay dividends

    What sector is Radiopharm Theranostics Limited in?

    Radiopharm Theranostics Limited is in the Healthcare sector

    What industry is Radiopharm Theranostics Limited in?

    Radiopharm Theranostics Limited is in the Biotechnology industry

    What country is Radiopharm Theranostics Limited based in?

    Radiopharm Theranostics Limited is headquartered in Australia

    When did Radiopharm Theranostics Limited go public?

    Radiopharm Theranostics Limited's initial public offering (IPO) was on December 5, 2024

    Is Radiopharm Theranostics Limited in the S&P 500?

    No, Radiopharm Theranostics Limited is not included in the S&P 500 index

    Is Radiopharm Theranostics Limited in the NASDAQ 100?

    No, Radiopharm Theranostics Limited is not included in the NASDAQ 100 index

    Is Radiopharm Theranostics Limited in the Dow Jones?

    No, Radiopharm Theranostics Limited is not included in the Dow Jones index

    When was Radiopharm Theranostics Limited's last earnings report?

    Radiopharm Theranostics Limited's most recent earnings report was on August 29, 2025

    When does Radiopharm Theranostics Limited report earnings?

    The date for Radiopharm Theranostics Limited's next earnings report has not been announced yet
    On this page